Vaccine Antigen

Age at Initial Vaccination

Booster Interval

Panel Comments

Under 12 weeks

Over 12 weeks

Panleukopenia
parenteral MLV
intranasal MLV

vaccinate at initial visit and then every 3-4 wks until >12 weeks ¹

1 dose

1 year later, then every 3 years

Highly recommended. Not for use in pregnant queens or kittens <4 wks or immune compromised

Panleukopenia
killed

vaccinate at initial visit and then every 3-4 wks until >12 weeks

2 doses
3-4 wks apart

1 year later, then every 3 years

Highly recommended

FHV-1/FCV ^{* 2}
parenteral MLV
intranasal MLV

vaccinate at initial visit and then every 3-4 wks until >12 weeks

1 dose

1 year later, then every 3 years ³

Highly recommended

FHV-1/FCV ^*
killed

vaccinate at initial visit and then every 3-4 wks until >12 weeks

2 doses
3-4 wks apart

1 year later, then every 3 years ³

Highly recommended

Rabies
killed

1 dose

1 year later, then every 3 years ⁵

Highly recommended for all cats

Chlamydia
avirulent live

1 dose

1 dose

1 year later, then annually

Recommended for use in cats at high risk of exposure

Chlamydia
killed

2 doses
3-4 wks apart

2 doses
3-4 wks apart

1 year later, then annually

Recommended for use in cats at high risk of exposure

FIP
intranasal MLV

2 doses
3-4 wks apart not earlier than 16 wks

1 year later, then annually

It is reasonable to vaccinate cats at risk of exposure to other cats with known or clinically suspected exposure to feline corona virus

FeLV
killed

2 doses
3-4 wks apart;
1st dose > 8 wks;
2nd dose >12 wks

2 doses
3-4 wks apart

1 year later, then annually

Follow testing recommendations as published in the AAFP/AFM Recommendation for Feline Retrovirus Testing. Recommended for use in cats with high risk ⁴ of exposure.

M. Canis
killed

Prevention:
3 doses; 2 wks between 1st and 2nd, then 3rd dose 3 wks after 2nd dose.
Treatment:
3 doses; 2 wks between 1st and 2nd, then 3rd dose 3 wks after 2nd dose. 3rd dose is at DVM discretion.

Guidelines for long term use or booster intervals not available

Not recommended for routine use. Insufficient data to evaluate use in prevention or elimination of M. Canis infection.